Schott Pharma & (1SXP.DE) traded flat 0 % during a 24 hours period ending at 08:05 AM Central Europe on Wednesday 28th. One Schott Pharma & stock can currently be bought for about EUR 25.5 on popular exchanges. Current supply of Schott Pharma & stocks is 150.9 mn. Schott Pharma & has a current market capitalization of EUR 3.8 bn and approximately EUR 1.4 mn worth of Schott Pharma & was traded on exchanges in the last 24 hours. Since last month end, Schott Pharma & has traded 2 % up. Simple moving average of last 200 days is at EUR 18.4. The highest price of past 52 weeks was recorded at EUR 26.2 on 10/21/2026. 52 weeks low was at EUR 12.62 on 03/23/2026.

Here is how related stocks have performed in the past 24 hours:

  • Wacker Chemie (WCH.DE) traded up 1.73 % and now trades at EUR 82.35. Current market capitalisation for Wacker Chemie is EUR 4.1 bn.

  • 1&1 (1U1.DE) traded up 0.42 % and now trades at EUR 23.65. 1&1 has a market capitalisation of EUR 4.2 bn. 1&1 has a current price to earnings ratio of 34.66.

  • Kion (KGX.DE) traded up 1.38 % and now trades at EUR 33.91. Kion has a market capitalisation of EUR 4.4 bn. Kion has a current price to earnings ratio of 11.38. KION GROUP AG reported a net short‑sale position of roughly nine‑tenths of one percent of its issued share capital on 26 October 2026, as disclosed by Ilex Capital Partners (UK) LLP in the German Federal Gazette. The filing indicated that a single market participant held this position for the KION GROUP AG ISIN DE000KGX8881. In a separate market‑analysis article, finanzen.net highlighted that an investment of one thousand euros made in the company’s stock ten years earlier would now be worth less than its original outlay, reflecting a decline in share value. The piece noted that the stock had traded at about thirty‑three euros on 26 October 2026, down from a closing price of around fifty‑five euros a decade earlier. The article also referenced KION GROUP’s recent market capitalization of approximately 4.4 billion euros.

  • Springer Nature & (SPG.DE) traded down -0.72 % and now trades at EUR 20.7. Current market capitalisation for Springer Nature & is EUR 4.2 bn. Springer Nature & has a current price to earnings ratio of 12.15.

  • Puma (PUM.DE) traded down -2.59 % and now trades at EUR 24.81. Puma has a market capitalisation of EUR 3.7 bn. PUMA SE has recently disclosed a short‑sale position of its own shares, with two institutional holders reporting holdings of roughly one and a half percent of the company’s issued equity. The filing, dated 26 October 2026, was made public through the German Federal Gazette. No accompanying commentary on the company’s financial performance or strategic direction was provided in the announcement. The disclosure focuses solely on the ownership detail, indicating that the share count represents a modest fraction of the total outstanding shares and that the holders are not in a position of significant influence over corporate governance. No further information about the intent behind the short‑sale activity or its potential impact on share price movements is included in the report.

About Schott Pharma &

The Schott Pharma AG & Co. KGaA is a health care sector company located in Mainz, Germany. The company specializes in providing drug containment and drug delivery solutions. SCHOTT Pharma offers prefillable syringes, cartridges, vials, and ampoules for analytical, development, fill-and-finish, and regulatory services for pharmaceutical companies, biotechs, and CDMOs. The company serves customers worldwide and can be accessed through their website at www.schott-pharma.com . SCHOTT Pharma is listed on the Xetra stock exchange.